Subcutaneous Administration of a 10-Fold-Lower Dose of a Commercial Human Tuberculosis Vaccine, Mycobacterium bovis Bacillus Calmette-Guérin Danish, Induced Levels of Protection against Bovine Tuberculosis and Responses in the Tuberculin Intradermal Test Similar to Those Induced by a Standard Cattle Dose

Duration of Immunity against Mycobacterium bovis following Neonatal Vaccination with Bacillus Calmette-Guérin Danish: Significant Protection against Infection at 12, but Not 24, Months

(2012) M. L. Thom et al.   Clinical and Vaccine Immunology

Bovine tuberculosis vaccine research: Historical perspectives and recent advances

(2012) W. Ray Waters et al.   VACCINE

Advances in ante-mortem diagnosis of tuberculosis in cattle

(2011) BM Buddle et al.   NEW ZEALAND VETERINARY JOURNAL

Lack of correlation between BCG-induced tuberculin skin test sensitisation and protective immunity in cattle

(2011) A.O. Whelan et al.   VACCINE

Mycobacterium bovis antigens for the differential diagnosis of vaccinated and infected cattle

(2011) Martin Vordermeier et al.   VETERINARY MICROBIOLOGY

Field Evaluation of the Efficacy of Mycobacterium bovis Bacillus Calmette-Guerin against Bovine Tuberculosis in Neonatal Calves in Ethiopia

(2010) G. Ameni et al.   Clinical and Vaccine Immunology

Development of a Skin Test for Bovine Tuberculosis for Differentiating Infected from Vaccinated Animals

(2010) A. O. Whelan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis

(2009) H. M. Vordermeier et al.   INFECTION AND IMMUNITY